TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 122 filers reported holding TG THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,113,628 | -35.3% | 611,678 | +92.2% | 0.02% | -37.5% |
| Q2 2023 | $7,905,827 | +2441.7% | 318,270 | +1438.9% | 0.02% | +2300.0% |
| Q1 2023 | $311,042 | -88.0% | 20,681 | -95.3% | 0.00% | -90.0% |
| Q3 2022 | $2,588,000 | +2231.5% | 437,200 | +2103.1% | 0.01% | +900.0% |
| Q3 2019 | $111,000 | -98.2% | 19,845 | -97.2% | 0.00% | -96.9% |
| Q2 2019 | $6,055,000 | -41.1% | 700,000 | -45.3% | 0.03% | -31.9% |
| Q1 2019 | $10,282,000 | +19.9% | 1,278,900 | +111.8% | 0.05% | +30.6% |
| Q1 2018 | $8,574,000 | – | 603,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |